Pharmaceutical Sciences Research Centre

During a working visit and inspection tour in Constantine, the Minister of Pharmaceutical Industry, Wassim Kouidri, stopped off at the Centre for Pharmaceutical Research (CRSP), located in the new town of Ali Mendjeli. Accompanied by the Wali of Constantine, Abdelkhalek Sayouda, the minister inspected the various facilities at this establishment, considered to be the first of its kind in the country.

Created by Executive Decree No. 18-245 of 9 October 2018 and launched in 2021, in the height of the Covid-19 health crisis, the CRSP quickly established itself as an essential link in the development of a pharmaceutical industry based on research and innovation.

Its main mission is to promote research into the active ingredients of medicines and to control pharmaceutical efficacy based on fundamental knowledge. During his tour, the minister inquired about the scientific activities carried out by the centre's teams. In particular, he discovered several innovative projects, including a prototype photopolymerisation lamp for dentistry and the use of 3D printing technology for drug packaging.

The laboratories visited cover several strategic areas, ranging from the development of biopharmaceuticals to the modernisation of pharmaceutical manufacturing processes. The centre also aims to strengthen pharmacology, particularly in the management of chronic diseases, and to contribute to health safety.

Its priorities also include promoting research into anti-doping measures and improving therapeutic tolerance to medicines and their derivatives.

During the Covid-19 pandemic, the CRSP distinguished itself by conducting bioequivalence studies on generic drugs and setting up a scientific monitoring system dedicated to Covid-19. It also obtained its first patent from INAPI, recognising the work of a young team of researchers committed to promoting scientific results. With its own research programme, the centre also acts as a service provider for pharmaceutical production laboratories. It is working to develop expertise capable of meeting the growing demands of public health and the challenges of industrial development.

During this visit, the minister emphasised the strategic importance of such structures in strengthening the country's health sovereignty.

The CRSP thus appears to be a key factor in building an innovative, competitive pharmaceutical industry that is firmly focused on scientific research and serving citizens' health.